Brief: Amneal Pharma To Settle Majority Of Opioids-Related Claims
Jan 28 (Reuters) - Amneal Pharmaceuticals Inc AMRX.O: AMNEAL PHARMA - TO SETTLE MAJORITY OF OPIOIDS-RELATED CLAIMS - SEC FILING AMNEAL PHARMA - OPIOIDS SETTLEMENT AGREEMENT EFFECTIVE JANUARY 29, 2026 - SEC FILING AMNEAL PHARMA - TO PAY $88.5 MILLION UNDER OPIOIDS SETTLEMENT - SEC FILING AMNEAL PHARMA - TO PROVIDE $177.4 MILLION IN NALOXONE NASAL SPRAY TO HELP TREAT OPIOID OVERDOSES - SEC FILING Further company coverage: AMRX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Amneal Pharmaceuticals
See all newsFocus: US progesterone supplies tighten as menopause treatment demand grows
U.S. STOCKS ON THE MOVE-Chipotle Mexican Grill, J.B. Hunt, ABM Industries
U.S. STOCKS ON THE MOVE-G-III Apparel, Amneal Pharmaceuticals, BioCardia
U.S. STOCKS ON THE MOVE-Lululemon, Cooper Companies, Cypherpunk Technologies
Amneal Pharma up after Parkinson’s drug shows benefit in late-stage study